improving gene therapy viral vector manufacturing economics modelling bioprocess costs
Published 3 months ago • 17 plays • Length 35:06Download video MP4
Download video MP3
Similar videos
-
12:27
improving plasmid design, process and manufacturing to improve viral vector yield
-
38:30
enabling large-scale production of viral vectors in the gibco™ cts lv-max lentiviral....
-
19:17
viral vector empty versus full and plasmid quantitation analytics for accelerated gene therapy....
-
20:34
technology-ready processes for gene therapy manufacturing 2.0
-
16:06
an end to end integrated solutions approach to commercial viral vector manufacturing
-
33:07
accelerate cell and gene therapy development and increase manufacturing capacity....
-
20:38
2.5× lentiviral vector bioreactor yield increase and simplified execution....
-
22:33
wuxi advanced therapies virology operations: cell & gene therapy vector regulatory testing
-
19:08
lentiviral vector platform generation: increase titer and yield with greater predictability
-
36:01
flexible and customized approach to lentiviral vector development and manufacture
-
25:06
formulation and characterization strategies for gene therapies
-
19:04
the expanding dna and gene therapy market
-
21:02
simplify analytical development for measuring residual plasmid dna in mrna, gene therapy, and other
-
48:34
modernize your gene therapy analytics with automated tools from bio techne
-
23:35
gene therapy product analytics: where historical and modern techniques meet
-
3:43
gene therapy workflow from production to quality control
-
31:36
from genetic design to bioprocess performance - bioprocessing summit 2024
-
21:29
development of lentivex™ packaging and producer cell lines for lentivirus manufacture
-
13:06
promoter discovery for optimized viral vector development